How California Institute for regenerative medicine research programs support science and regulatory policy

摘要

Effective science policy has been central to the development of stem cell research. The California Institute for Regenerative Medicine (CIRM) is a case in point. The institute exists because more than 7 million California voters endorsed Proposition 71 in 2004. In parallel, related and complementary national and international policy initiatives have been developed, contributing to accelerated growth in the field. As an example of this growth, between 2004 and 2010, the annual rate of "stem cell" publications increased more than 30-fold [1].CIRM is cognizant of the critical roles that science and regulatory policy play in advancing stem cell research. The institute sustains a programmatic focus on state, national, and international regulatory policy issues impacting basic research and translational medicine. CIRM deploys a variety of mechanisms including conducting policy research, convening advisory committees, and establishing collaborative partnerships. This focus is vital for advancing the institute's mission to support the development of safe and effective therapies, with the long-term goal of improving healthcare.